TY - JOUR
T1 - Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes
AU - Basu, Rita
AU - Schwenk, W. Frederick
AU - Rizza, Robert A.
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2004/7
Y1 - 2004/7
N2 - To determine whether regulation of fasting endogenous glucose production (EGP) and glucose disappearance (Rd) are both abnormal in people with type 2 diabetes, EGP and Rd were measured in 7 "severe" (SD), 9 "mild" (MD), and 12 nondiabetic (ND) subjects (12.7 ± 0.6 vs. 8.1 ± 0.4 vs. 5.1 ± 0.4 mmol/l) after an overnight fast and during a hyperglycemic pancreatic clamp. Fasting insulin was higher in both the SD and MD than ND subjects, whereas fasting glucagon only was increased (P < 0.05) in SD. Fasting EGP, glycogenolysis, gluconeogenesis, and R d all were increased (P < 0.05) in SD but did not differ in MD or ND. On the other hand, when glucose (∼11 mmol/l), insulin (∼72 pmol/l), and glucagon (∼140 pg/ml) concentrations were raised to values similar to those observed in the severe diabetic subjects, EGP was higher (P < 0.001) and Rd lower (P < 0.01) in both SD and MD than in ND. The higher EGP in the SD and MD than ND during the clamp was the result of increased (P < 0.05) rates of glycogenolysis (4.2 ± 1.7 vs. 3.5 ± 1.0 vs. 0.0 ± 0.8 μmol·kg-1·min-1), since gluconeogenesis did not differ among groups. We conclude that neither glucose production nor disappearance is appropriate for the prevailing glucose and insulin concentrations in people with mild or severe diabetes. Both increased rates of gluconeogenesis (likely because of higher glucagon concentrations) and lack of suppression of glycogenolysis contribute to excessive glucose production in type 2 diabetics.
AB - To determine whether regulation of fasting endogenous glucose production (EGP) and glucose disappearance (Rd) are both abnormal in people with type 2 diabetes, EGP and Rd were measured in 7 "severe" (SD), 9 "mild" (MD), and 12 nondiabetic (ND) subjects (12.7 ± 0.6 vs. 8.1 ± 0.4 vs. 5.1 ± 0.4 mmol/l) after an overnight fast and during a hyperglycemic pancreatic clamp. Fasting insulin was higher in both the SD and MD than ND subjects, whereas fasting glucagon only was increased (P < 0.05) in SD. Fasting EGP, glycogenolysis, gluconeogenesis, and R d all were increased (P < 0.05) in SD but did not differ in MD or ND. On the other hand, when glucose (∼11 mmol/l), insulin (∼72 pmol/l), and glucagon (∼140 pg/ml) concentrations were raised to values similar to those observed in the severe diabetic subjects, EGP was higher (P < 0.001) and Rd lower (P < 0.01) in both SD and MD than in ND. The higher EGP in the SD and MD than ND during the clamp was the result of increased (P < 0.05) rates of glycogenolysis (4.2 ± 1.7 vs. 3.5 ± 1.0 vs. 0.0 ± 0.8 μmol·kg-1·min-1), since gluconeogenesis did not differ among groups. We conclude that neither glucose production nor disappearance is appropriate for the prevailing glucose and insulin concentrations in people with mild or severe diabetes. Both increased rates of gluconeogenesis (likely because of higher glucagon concentrations) and lack of suppression of glycogenolysis contribute to excessive glucose production in type 2 diabetics.
KW - Fasting hyperglycemia
KW - Insulin resistance
KW - Liver
UR - http://www.scopus.com/inward/record.url?scp=3042701667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042701667&partnerID=8YFLogxK
U2 - 10.1152/ajpendo.00549.2003
DO - 10.1152/ajpendo.00549.2003
M3 - Article
C2 - 14982753
AN - SCOPUS:3042701667
SN - 0193-1849
VL - 287
SP - E55-E62
JO - American Journal of Physiology - Endocrinology and Metabolism
JF - American Journal of Physiology - Endocrinology and Metabolism
IS - 1 50-1
ER -